These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
343 related items for PubMed ID: 18292232
21. Inducible tumor necrosis factor (TNF) receptor-associated factor-1 expression couples the canonical to the non-canonical NF-κB pathway in TNF stimulation. Choudhary S, Kalita M, Fang L, Patel KV, Tian B, Zhao Y, Edeh CB, Brasier AR. J Biol Chem; 2013 May 17; 288(20):14612-14623. PubMed ID: 23543740 [Abstract] [Full Text] [Related]
22. Noncanonical NF-κB signaling is limited by classical NF-κB activity. Gray CM, Remouchamps C, McCorkell KA, Solt LA, Dejardin E, Orange JS, May MJ. Sci Signal; 2014 Feb 04; 7(311):ra13. PubMed ID: 24497610 [Abstract] [Full Text] [Related]
23. B-cell CLL/lymphoma 10 (BCL10) is required for NF-kappaB production by both canonical and noncanonical pathways and for NF-kappaB-inducing kinase (NIK) phosphorylation. Bhattacharyya S, Borthakur A, Tyagi S, Gill R, Chen ML, Dudeja PK, Tobacman JK. J Biol Chem; 2010 Jan 01; 285(1):522-30. PubMed ID: 19897484 [Abstract] [Full Text] [Related]
24. Lipopolysaccharide-induced activation of NF-κB non-canonical pathway requires BCL10 serine 138 and NIK phosphorylations. Bhattacharyya S, Borthakur A, Dudeja PK, Tobacman JK. Exp Cell Res; 2010 Nov 15; 316(19):3317-27. PubMed ID: 20466000 [Abstract] [Full Text] [Related]
26. CDK12-mediated transcriptional regulation of noncanonical NF-κB components is essential for signaling. Henry KL, Kellner D, Bajrami B, Anderson JE, Beyna M, Bhisetti G, Cameron T, Capacci AG, Bertolotti-Ciarlet A, Feng J, Gao B, Hopkins B, Jenkins T, Li K, May-Dracka T, Murugan P, Wei R, Zeng W, Allaire N, Buckler A, Loh C, Juhasz P, Lucas B, Ennis KA, Vollman E, Cahir-McFarland E, Hett EC, Ols ML. Sci Signal; 2018 Jul 31; 11(541):. PubMed ID: 30065029 [Abstract] [Full Text] [Related]
27. Methods to assess the activation of the alternative (noncanonical) NF-κB pathway by non-death TNF receptors. Remouchamps C, Dejardin E. Methods Mol Biol; 2015 Jul 31; 1280():103-19. PubMed ID: 25736746 [Abstract] [Full Text] [Related]
28. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation. Luftig M, Yasui T, Soni V, Kang MS, Jacobson N, Cahir-McFarland E, Seed B, Kieff E. Proc Natl Acad Sci U S A; 2004 Jan 06; 101(1):141-6. PubMed ID: 14691250 [Abstract] [Full Text] [Related]
30. A fourth IkappaB protein within the NF-kappaB signaling module. Basak S, Kim H, Kearns JD, Tergaonkar V, O'Dea E, Werner SL, Benedict CA, Ware CF, Ghosh G, Verma IM, Hoffmann A. Cell; 2007 Jan 26; 128(2):369-81. PubMed ID: 17254973 [Abstract] [Full Text] [Related]
31. XEDAR activates the non-canonical NF-κB pathway. Verhelst K, Gardam S, Borghi A, Kreike M, Carpentier I, Beyaert R. Biochem Biophys Res Commun; 2015 Sep 18; 465(2):275-80. PubMed ID: 26260321 [Abstract] [Full Text] [Related]
32. Carboxyl terminus of HSC70-interacting protein (CHIP) down-regulates NF-κB-inducing kinase (NIK) and suppresses NIK-induced liver injury. Jiang B, Shen H, Chen Z, Yin L, Zan L, Rui L. J Biol Chem; 2015 May 01; 290(18):11704-14. PubMed ID: 25792747 [Abstract] [Full Text] [Related]
33. The C-terminal activating region 2 of the Epstein-Barr virus-encoded latent membrane protein 1 activates NF-kappaB through TRAF6 and TAK1. Wu L, Nakano H, Wu Z. J Biol Chem; 2006 Jan 27; 281(4):2162-9. PubMed ID: 16280329 [Abstract] [Full Text] [Related]
34. TACI induces cIAP1-mediated ubiquitination of NIK by TRAF2 and TANK to limit non-canonical NF-kappaB signaling. Kanno Y, Sakurai D, Hase H, Kojima H, Kobata T. J Recept Signal Transduct Res; 2010 Apr 27; 30(2):121-32. PubMed ID: 20184394 [Abstract] [Full Text] [Related]
35. Targeting signaling factors for degradation, an emerging mechanism for TRAF functions. Yang XD, Sun SC. Immunol Rev; 2015 Jul 27; 266(1):56-71. PubMed ID: 26085207 [Abstract] [Full Text] [Related]
36. A TNF-p100 pathway subverts noncanonical NF-κB signaling in inflamed secondary lymphoid organs. Mukherjee T, Chatterjee B, Dhar A, Bais SS, Chawla M, Roy P, George A, Bal V, Rath S, Basak S. EMBO J; 2017 Dec 01; 36(23):3501-3516. PubMed ID: 29061763 [Abstract] [Full Text] [Related]
37. APPL1 regulates basal NF-κB activity by stabilizing NIK. Hupalowska A, Pyrzynska B, Miaczynska M. J Cell Sci; 2012 Sep 01; 125(Pt 17):4090-102. PubMed ID: 22685329 [Abstract] [Full Text] [Related]
38. CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase. Akiba H, Nakano H, Nishinaka S, Shindo M, Kobata T, Atsuta M, Morimoto C, Ware CF, Malinin NL, Wallach D, Yagita H, Okumura K. J Biol Chem; 1998 May 22; 273(21):13353-8. PubMed ID: 9582383 [Abstract] [Full Text] [Related]
39. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling. Cherry EM, Lee DW, Jung JU, Sitcheran R. Mol Cancer; 2015 Jan 27; 14(1):9. PubMed ID: 25622756 [Abstract] [Full Text] [Related]
40. Activation-induced tumor necrosis factor receptor-associated factor 3 (Traf3) alternative splicing controls the noncanonical nuclear factor κB pathway and chemokine expression in human T cells. Michel M, Wilhelmi I, Schultz AS, Preussner M, Heyd F. J Biol Chem; 2014 May 09; 289(19):13651-60. PubMed ID: 24671418 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]